Investor positioning shifts as European banks and tech take the lead

Fidelity European Trust

European markets began the week with modest but telling strength. While the overall move was measured, the underlying shifts in sector leadership point to a change in how capital is being allocated. Tech and banking stocks led gains across the Stoxx Europe 600, with technology rising over 1 % and financials not far behind. These are not speculative rotations.

Driving sentiment is a recalibration of macro risk. Softer US inflation data has strengthened the case for the Federal Reserve to begin easing, with a potential rate cut back on the table as early as March. That has filtered across to European markets, particularly as it coincides with better-than-expected corporate results. Notably, German business sentiment indicators ticked higher, reinforcing confidence that economic activity across the eurozone may be stabilising after months of strain.

Banks are benefiting from improved net interest margin expectations, while technology stocks are attracting capital on the back of durable demand for hardware and AI-linked infrastructure. Export-heavy names are also starting to see valuation support, helped by a more constructive view on global trade following an easing in US–China tensions. At the same time, defensives like healthcare and insurance continue to see steady inflows.

Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Investing in Europe: Why investors should remain positive

Co-Portfolio Manager of the Fidelity European Trust PLC (LON:FEV), outlines why he believes quality businesses backed by strong balance sheets and dividend growth potential remain well placed to deliver strong

Fidelity European Trust rises in August, reporting 16.4% returns in 2025

Fidelity European Trust highlighted strong contributions in August 2025 from KBC Groupe, which upgraded full year guidance, and Novo Nordisk, which advanced on positive trial results and regulatory approval for

Fidelity European Trust Factsheet – July volatility, Legrand and Bankinter gains

Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and

European Investment Opportunities – Fidelity’s Quality Focus (LON:FEV)

FEV portfolio manager Marcel Stotzel highlights how quality companies with strong defensive characteristics can help investors navigate uncertainty and achieve long-term growth.

16.7% YTD return hails Fidelity European Trust’s strong credentials

Despite market headwinds, the Trust demonstrated resilience with standout contributions from Legrand and EQT and positive sector positioning. Over the past 12 months, NAV rose 2.3% and share price 5.5%,

Fidelity European Trust May Factsheet – European equities moved higher

European equities rose in May amid volatility linked to US trade uncertainty. Fidelity European Trust underperformed the index, mainly due to weak positions in consumer sectors.

Search

Search